Determination of stavudine in human plasma and urine by high-performance liquid chromatography using a reduced sample volume
- 8 September 2000
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 746 (2) , 183-189
- https://doi.org/10.1016/s0378-4347(00)00324-8
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialThe Lancet, 1999
- The Ariel Project: A Prospective Cohort Study of Maternal‐Child Transmission of Human Immunodeficiency Virus Type 1 in the Era of Maternal Antiretroviral TherapyThe Journal of Infectious Diseases, 1999
- Antiretroviral therapies in pregnancyAIDS, 1998
- Clinical Pharmacokinetics of StavudineClinical Pharmacokinetics, 1997
- Prenatal and postpartum pharmacokinetics of stavudine (2',3'-didehydro-3'-deoxythymidine) and didanosine (dideoxyinosine) in pigtailed macaques (Macaca nemestrina)Antimicrobial Agents and Chemotherapy, 1996
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994
- Determination of stavudine, a new antiretroviral agent, in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- High-performance liquid chromatographic determination of 2′,3′-didehydro-3′-deoxythymidine, a new anti-human immunodeficiency virus agent, in human plasma and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- Chromatographic methods for the bioanalysis of antiviral agentsJournal of Chromatography B: Biomedical Sciences and Applications, 1990